多国整群随机对照试验研究方案:多组分同一健康策略消除下湄公河流域麝猫后睾吸虫与土源性线虫的影响
本研究为在柬埔寨、老挝和泰国18个农村社区开展的整群随机对照试验,比较单轮吡喹酮/阿苯达唑治疗与多组分同一健康综合干预(含药物治疗、魔法眼镜和Lawa模型)对5-75岁人群麝猫后睾吸虫和土源性线虫感染累积发病率的影响,随访12个月。
要点
- 多组分同一健康干预包括吡喹酮/阿苯达唑治疗、魔法眼镜和Lawa模型健康教育。
- 主要结局为5-75岁人群麝猫后睾吸虫和土源性线虫感染的累积发病率。
- 18个农村社区随机分为干预组和对照组,随访12个月比较两组结局。
核心结论
- 该试验将量化多组分同一健康控制策略在下湄公河流域阻断麝猫后睾吸虫和土源性线虫感染的影响。
研究设计与样本
- 在柬埔寨、老挝和泰国18个农村社区(以街道或村庄为整群单位)开展整群随机对照试验。
- 对照组接受一轮吡喹酮/阿苯达唑治疗,干预组实施多组分同一健康蠕虫消除项目(HELM),包括吡喹酮/阿苯达唑治疗、魔法眼镜和Lawa模型干预。
- 在基线及HELM干预后12个月随访时,采用改良甲醛乙酸乙酯浓缩技术和定量PCR评估5-75岁人群麝猫后睾吸虫和土源性线虫感染水平。
主要发现
- 原文未报告结果数据。
关键数值与推荐
- 主要结局为人类麝猫后睾吸虫和土源性线虫感染的累积发病率。
- 采用广义线性混合模型比较研究组间结局,并考虑整群效应。
- 试验注册于澳大利亚新西兰临床试验注册中心(ANZCTR):ACTRN12622000353796,于2022年2月28日前瞻性注册。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opisthorchis viverrini (OV) and soil-transmitted helminths (STH) are two of the most common helminths contributing to the Neglected Tropical Disease (NTDs) burden in the Lower Mekong Basin. Although mass drug administration is the cornerstone of control programs to reduce morbidity caused by these infections, this approach has limitations in preventing re-infections. Elimination requires additional measures such as reservoir host treatment, improved hygiene and health education to reinforce MDA's impact. This study aims to examine the impact of a scalable multi-component One Health Helminth Elimination program in the Lower Mekong Basin (HELM) that combines human praziquantel (PZQ) and albendazole (ALB) treatment with a program that includes the "Magic Glasses" and the "Lawa Model" interventions with health promotion at their core. METHODS: This study will employ a cluster randomized controlled trial (cRCT) in 18 rural communities (with sub-district or villages as cluster units) across Cambodia, Laos and Thailand. The control arm will receive one round of PZQ/ALB treatment, while in the intervention arm, multi-component HELM program will be implemented, which includes PZQ/ALB treatment together with the Magic Glasses and Lawa Model interventions. OV and STH infections levels will be evaluated in individuals aged 5-75 years at baseline and will be repeated at follow-up (12 months after the HELM intervention), using modified formalin ethyl-acetate concentration technique and quantitative PCR. The primary outcome of the study will be cumulative incidence of human OV and STH infections. Outcomes between the study arms will be compared using generalized linear mixed models, accounting for clustering. DISCUSSION: Evidence from this trial will quantify the impact of a multi-component One Health control strategy in interrupting Ov and STH infections in the Lower Mekong Basin. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12622000353796. Prospectively registered 28 February 2022.
引用
- Mationg ML, Clements ACA, Williams GM, et al. A study protocol for a multi-country cluster randomized controlled trial of the impact of a multi-component One Health strategy to eliminate Opisthorchis viverrini and soil transmitted helminths in the Lower Mekong Basin. Trials. 2024. PMID: 39605028. doi:10.1186/s13063-024-08616-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。